Global News Post Fastest Global News Portal
Related Articles
23andMe Founder and Board Member Anne Wojcicki speaks all through a House Committee on Oversight and Government Reform listening to on June 10, 2025 in Washington, DC.
Andrew Harnik | Getty Images
Anne Wojcicki, the co-founder and previous CEO of 23andMe, has regained regulate over the embattled genetic trying out corporate after her new nonprofit, TTAM Research Institute, out bid Regeneron Pharmaceuticals, the corporate introduced on Friday.
TTAM will achieve considerably all of 23andMe’s belongings for $305 million, together with its Personal Genome Service and Research Services trade strains in addition to telehealth subsidiary Lemonaid Health. It’s a large win for Wojcicki, who stepped down from her function as CEO when 23andMe filed for for Chapter 11 chapter coverage in March.
Last month, Regeneron introduced that it could acquire maximum of 23andMe’s belongings for $256 million after it got here out on most sensible all through a chapter public sale. But Wojcicki submitted a separate $305 million bid via TTAM and driven to reopen the public sale. TTAM is an acronym for the primary letters of 23andMe, in keeping with the Wall Street Journal.
“I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki stated in a remark.
23andMe won recognition on account of its at-home DNA trying out kits that gave consumers perception into their circle of relatives histories and genetic profiles. The five-time CNBC Disruptor 50 corporate went public in 2021 by way of a merger with a different objective acquisition corporate. At its height, 23andMe was once valued at round $6 billion.
The corporate struggled to generate ordinary income and rise up viable analysis and therapeutics companies after going public, and it is been plagued through privateness issues since hackers accessed the ideas of just about 7 million consumers in 2023.
TTAM’s acquisition continues to be topic to approval through the U.S. Bankruptcy Court for the Eastern District of Missouri.
